SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-058659
Filing Date
2024-05-13
Accepted
2024-05-13 16:10:32
Documents
54
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q annx-20240331.htm   iXBRL 10-Q 1764813
2 EX-31.1 annx-ex31_1.htm EX-31.1 15746
3 EX-31.2 annx-ex31_2.htm EX-31.2 15251
4 EX-32.1 annx-ex32_1.htm EX-32.1 13667
  Complete submission text file 0000950170-24-058659.txt   6325838

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT annx-20240331.xsd EX-101.SCH 883382
57 EXTRACTED XBRL INSTANCE DOCUMENT annx-20240331_htm.xml XML 965916
Mailing Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005
Business Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005 (650)-822-5500
Annexon, Inc. (Filer) CIK: 0001528115 (see all company filings)

IRS No.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39402 | Film No.: 24939147
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)